Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
02/20/20183:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/20/201810:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/14/20182:42PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
02/14/201810:28AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/14/201810:20AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/14/20189:40AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/14/20189:28AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/13/20183:50PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/09/20185:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
02/09/20185:30AMBusiness WireImmunoGen Reports Pipeline Progress and 2017 Operating ResultsNASDAQ:IMGNImmunoGen Inc
02/08/20183:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
02/08/20182:05PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
02/06/20183:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
02/01/20188:32AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
01/26/20187:00AMBusiness WireImmunoGen Announces Conference Call to Discuss Its 2017 Operating ResultsNASDAQ:IMGNImmunoGen Inc
01/24/201810:13AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
01/24/20187:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
01/24/20187:00AMBusiness WireImmunoGen Appoints Stuart A. Arbuckle to Board of DirectorsNASDAQ:IMGNImmunoGen Inc
01/09/20183:00PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:IMGNImmunoGen Inc
01/08/20182:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/08/20188:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
01/04/20187:00AMBusiness WireImmunoGen Announces First Patient Dosed in Phase 1 Study of IMGN632 for Hematological MalignanciesNASDAQ:IMGNImmunoGen Inc
01/03/201812:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/201812:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/201812:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/201812:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/02/20187:30AMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at the 36th Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
12/21/20172:08PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:IMGNImmunoGen Inc
12/13/20173:56PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
12/09/20174:30PMBusiness WireImmunoGen Presents New Clinical and Preclinical Data at ASH Annual MeetingNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN